Insider · CIK 0001871145

O'Byrne Jason

Reports to the SEC for 3 companies · SAN FRANCISCO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001871145

Forms 4 and 5

Insider transactions

18 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-01	OLMAOlema Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	CHIEF FINANCIAL OFFICER	AAward	+650K sh	—	—	650,000
2026-03-20	VIRVir Biotechnology, Inc.J Other	EVP & Chief Financial Officer	JOther	−2,500 sh	—	—	160,115
2026-03-20	VIRVir Biotechnology, Inc.J Other	EVP & Chief Financial Officer	JOther	+2,500 sh	—	—	2,500
2026-02-24	VIRVir Biotechnology, Inc.S Sale	EVP & Chief Financial Officer	SSale	−1,634 sh	$9.53	−$15.6K	162,615
2026-02-23	VIRVir Biotechnology, Inc.S Sale	EVP & Chief Financial Officer	SSale	−2,089 sh	$7.45	−$15.6K	164,249
2026-02-22	VIRVir Biotechnology, Inc.A Award	EVP & Chief Financial Officer	AAward	+55K sh	—	—	166,338
2026-02-22	VIRVir Biotechnology, Inc. · Stock Option (Right to Buy)A Award	EVP & Chief Financial Officer	AAward	+110K sh	—	—	110,000
2025-11-17	VIRVir Biotechnology, Inc.S Sale	EVP & Chief Financial Officer	SSale	−6,799 sh	$5.56	−$37.8K	110,701
2025-02-22	VIRVir Biotechnology, Inc.A Award	EVP & Chief Financial Officer	AAward	+40K sh	—	—	115,000
2025-02-22	VIRVir Biotechnology, Inc. · Stock Option (Right to Buy)A Award	EVP & Chief Financial Officer	AAward	+80K sh	—	—	80,000
2024-11-15	VIRVir Biotechnology, Inc.A Award	EVP & Chief Financial Officer	AAward	+75K sh	—	—	75,000
2024-11-15	VIRVir Biotechnology, Inc. · Stock Option (Right to Buy)A Award	EVP & Chief Financial Officer	AAward	+150K sh	—	—	150,000
2024-02-20	CRBUCaribou Biosciences, Inc.A Award	Chief Financial Officer	AAward	+33K sh	—	—	59,224
2024-02-20	CRBUCaribou Biosciences, Inc. · Option to purchase Common StockA Award	Chief Financial Officer	AAward	+153K sh	—	—	153,000
2023-02-21	CRBUCaribou Biosciences, Inc. · Option to purchase Common StockA Award	Chief Financial Officer	AAward	+131K sh	—	—	131,000
2022-02-08	CRBUCaribou Biosciences, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+24.3K sh	$4.11	+$100K	24,336
2022-02-08	CRBUCaribou Biosciences, Inc. · Option to purchase Common StockM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−24.3K sh	—	—	412,865
2021-12-20	CRBUCaribou Biosciences, Inc. · Option to purchase Common StockA Award	Chief Financial Officer	AAward	+147K sh	—	—	147,000

Recent filings

Accepted (ET)
Sep 24
O'Byrne Jason0001871145-26-000006
SEC(opens sec.gov)
Mar 234
O'Byrne Jason0001628280-26-020480
SEC(opens sec.gov)
Feb 264
O'Byrne Jason0001628280-26-012395
SEC(opens sec.gov)
Feb 244
O'Byrne Jason0001628280-26-011330
SEC(opens sec.gov)
Nov 184
O'Byrne Jason0001628280-25-052841
SEC(opens sec.gov)
Feb 254
O'Byrne Jason0001628280-25-007703
SEC(opens sec.gov)
Nov 184
O'Byrne Jason0001628280-24-048230
SEC(opens sec.gov)
Feb 224
O'Byrne Jason0001628280-24-006433
SEC(opens sec.gov)
Feb 234
O'Byrne Jason0001619856-23-000017
SEC(opens sec.gov)
Feb 84
O'Byrne Jason0001209191-22-007860
SEC(opens sec.gov)
Dec 214
O'Byrne Jason0001209191-21-070819
SEC(opens sec.gov)

Companies

Address

C/O OLEMA PHARMACEUTICALS, INC. 780 BRANNAN ST

SAN FRANCISCO, CA, 94103